Z-1018 (adjuvanted w/ CpG 1018)
Phase 1/2Shingles Vaccine
Data readoutStock, pipeline and biotech catalyst intelligence
Clinical portfolio
| Asset | Indication | Stage | Milestone | Signals ? |
|---|---|---|---|---|
| Z-1018 (adjuvanted w/ CpG 1018) | Shingles Vaccine | Phase 1/2 | Dec 31, 2026 | — |
| CpG 1018 | Pandemic influenza vaccines | Phase 1/2 | Dec 31, 2026 | — |
Upcoming milestones
Shingles Vaccine
Data readoutCompany profile
Dynavax Technologies is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.
Pandemic influenza vaccines
Data readout